Drug Search Results
Using advanced filters...
Advanced Search [+]

HY-100209

Alternative Names: HY-100209, HY 100209, HY100209
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Hefei Medical Engineering Pharmaceutical Co., Ltd./Hefei Enrui Pharmaceutical Co., Ltd.
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20242723

N/A

Active, not recruiting

Influenza, Human

None

Recent News Events

Date

Type

Title